Stretch-Induced Down-Regulation of HCN2 Suppresses Contractile Activity

Job Baffin Kola1, Botagoz Turarova1, Dora Csige1

  • 1Department of Medical Chemistry, School of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

PubMed

Insights

Hyperpolarization-activated and cyclic nucleotide-gated 2 channels (HCN2) are crucial for intestinal motility. Inhibiting HCN2 suppresses gut contractions, suggesting reduced HCN2 expression contributes to ileus.

Area of Science:

  • Gastroenterology
  • Physiology
  • Molecular Biology

Background:

  • Hyperpolarization-activated and cyclic nucleotide-gated 2 channels (HCN2) are present in the gut, but their function in intestinal motility remains unclear.
  • HCN2 expression is reduced in rodent models of ileus, indicating a potential role in this condition.

Purpose of the Study:

  • To investigate the impact of HCN2 inhibition on intestinal motility.
  • To explore the relationship between mechanical stretch, HCN2 expression, and intestinal function.

Main Methods:

  • Pharmacological inhibition of HCN2 using ZD7288 and zatebradine in rodent small intestine models.
  • Assessment of spontaneous and agonist-induced contractile activity, intestinal tone, and calcium sensitivity.
  • Evaluation of HCN2 protein and mRNA levels in response to mechanical stretch in vitro and in vivo.

Main Results:

  • HCN2 inhibition dose-dependently suppressed spontaneous and agonist-induced intestinal contractions and reduced intestinal tone.
  • Calcium sensitivity of contractile activity was significantly decreased by HCN2 inhibition.
  • Mechanical stretch, mimicking conditions like distension or edema, down-regulated HCN2 expression in intestinal smooth muscle and macrophages.

Conclusions:

  • Decreased HCN2 expression, potentially triggered by mechanical stimuli like intestinal distension or edema, may be a contributing factor to the development of ileus.
  • HCN2 plays a significant role in regulating intestinal smooth muscle contractility and tone.

Related Concept Videos

Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
3.4K
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
3.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
463
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
402
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.9K